APA (7th ed.) Citation

YF, C., YS, J., YC, C., CH, C., & JS, J. (2025). PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study. Psoriasis (Auckland, N.Z.), 15, 545. https://doi.org/10.2147/PTT.S563589

Chicago Style (17th ed.) Citation

YF, Chen, Jiang YS, Chen YC, Chang CH, and Jan JS. "PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study." Psoriasis (Auckland, N.Z.) 15 (2025): 545. https://doi.org/10.2147/PTT.S563589.

MLA (9th ed.) Citation

YF, Chen, et al. "PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study." Psoriasis (Auckland, N.Z.), vol. 15, 2025, p. 545, https://doi.org/10.2147/PTT.S563589.